PMC:7796041 / 15967-18723
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
431 | 39-50 | Disease | denotes | Arrhythmias | MESH:D001145 |
452 | 186-194 | Species | denotes | patients | Tax:9606 |
453 | 215-223 | Species | denotes | patients | Tax:9606 |
454 | 290-298 | Species | denotes | Patients | Tax:9606 |
455 | 456-464 | Species | denotes | patients | Tax:9606 |
456 | 757-765 | Species | denotes | patients | Tax:9606 |
457 | 813-821 | Species | denotes | patients | Tax:9606 |
458 | 1047-1055 | Species | denotes | patients | Tax:9606 |
459 | 707-725 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
460 | 859-871 | Chemical | denotes | azithromycin | MESH:D017963 |
461 | 1075-1093 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
462 | 100-111 | Disease | denotes | arrhythmias | MESH:D001145 |
463 | 139-147 | Disease | denotes | COVID-19 | MESH:C000657245 |
464 | 200-210 | Disease | denotes | arrhythmia | MESH:D001145 |
465 | 232-242 | Disease | denotes | arrhythmia | MESH:D001145 |
466 | 270-278 | Disease | denotes | COVID-19 | MESH:C000657245 |
467 | 304-315 | Disease | denotes | arrhythmias | MESH:D001145 |
468 | 366-378 | Disease | denotes | hypertension | MESH:D006973 |
469 | 383-405 | Disease | denotes | cardiovascular disease | MESH:D002318 |
470 | 470-480 | Disease | denotes | arrhythmia | MESH:D001145 |
471 | 678-686 | Disease | denotes | COVID-19 | MESH:C000657245 |
483 | 1893-1901 | Species | denotes | patients | Tax:9606 |
484 | 1211-1233 | Disease | denotes | cardiovascular disease | MESH:D002318 |
485 | 1238-1250 | Disease | denotes | hypertension | MESH:D006973 |
486 | 1285-1295 | Disease | denotes | arrhythmia | MESH:D001145 |
487 | 1452-1474 | Disease | denotes | cardiovascular disease | MESH:D002318 |
488 | 1530-1540 | Disease | denotes | arrhythmia | MESH:D001145 |
489 | 1544-1552 | Disease | denotes | COVID-19 | MESH:C000657245 |
490 | 1576-1588 | Disease | denotes | hypertension | MESH:D006973 |
491 | 1916-1926 | Disease | denotes | arrhythmia | MESH:D001145 |
492 | 1959-1969 | Disease | denotes | arrhythmia | MESH:D001145 |
493 | 2159-2169 | Disease | denotes | arrhythmia | MESH:D001145 |
499 | 2578-2582 | Gene | denotes | IL-6 | Gene:3569 |
500 | 2713-2716 | Gene | denotes | CRP | Gene:1401 |
501 | 2447-2455 | Species | denotes | patients | Tax:9606 |
502 | 2461-2471 | Disease | denotes | arrhythmia | MESH:D001145 |
503 | 2616-2626 | Disease | denotes | arrhythmia | MESH:D001145 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T103 | 39-50 | Phenotype | denotes | Arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T104 | 100-111 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T105 | 200-210 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T106 | 232-242 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T107 | 304-315 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T108 | 366-378 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T109 | 383-405 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T110 | 470-480 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T111 | 1211-1233 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T112 | 1238-1250 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T113 | 1285-1295 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T114 | 1452-1474 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T115 | 1530-1540 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T116 | 1576-1588 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T117 | 1916-1926 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T118 | 1959-1969 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T119 | 2159-2169 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T120 | 2461-2471 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T121 | 2616-2626 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T142 | 0-4 | Sentence | denotes | 3.3. |
T143 | 5-50 | Sentence | denotes | Clinical Predictors for New-Onset Arrhythmias |
T144 | 51-289 | Sentence | denotes | We analyzed predisposing factors associated with arrhythmias during hospitalization for COVID-19 comparing baseline characteristics of patients with arrhythmia and patients without arrhythmia during hospitalization for COVID-19 (Table 1). |
T145 | 290-416 | Sentence | denotes | Patients with arrhythmias were older and more often had been diagnosed with hypertension and cardiovascular disease (Table 1). |
T146 | 417-566 | Sentence | denotes | QTc duration at baseline was longer in patients with arrhythmia, however, median values were within the physiological range in both groups (Table 1). |
T147 | 567-687 | Sentence | denotes | Furthermore, we analyzed the prevalence of potentially proarrhythmic medication administered in the context of COVID-19. |
T148 | 688-790 | Sentence | denotes | In both subgroups, hydroxychloroquine was used in 44.1% and 44.6% of patients, respectively (Table 1). |
T149 | 791-872 | Sentence | denotes | A smaller fraction of patients in both groups additionally received azithromycin. |
T150 | 873-987 | Sentence | denotes | There was no statistically significant difference in the use of QT-prolonging drugs between both groups (Table 1). |
T151 | 988-1109 | Sentence | denotes | Median QTc-duration at baseline was within normal range in patients who later received hydroxychloroquine (409.0 ms; P25: |
T152 | 1110-1124 | Sentence | denotes | 390.5 ms, P75: |
T153 | 1125-1135 | Sentence | denotes | 421.5 ms). |
T154 | 1136-1306 | Sentence | denotes | Regularized logistic regression led to the selection of the variables age, cardiovascular disease and hypertension with respect to the prediction of arrhythmia incidence. |
T155 | 1307-1650 | Sentence | denotes | The subsequently fitted multiple logistic regression model revealed significant association of age (OR 1.036; 95% CI 1.004–1.074; p = 0.036) and cardiovascular disease (OR 3.307; 95% CI 1.329–8.232; p = 0.01) with incident arrhythmia in COVID-19, whereas the effect of hypertension was not significant (OR 2.08; 95% CI 0.794–5.796; p = 0.144). |
T156 | 1651-1741 | Sentence | denotes | As measure of the model’s performance an area under the curve (AUC) value of 0.74 (95% CI: |
T157 | 1742-1830 | Sentence | denotes | 0.65; 0.84) was estimated by applying 5-fold cross-validation (Supplementary Figure S1). |
T158 | 1831-1993 | Sentence | denotes | Left ventricular ejection fraction was documented in 47.1% of patients with incident arrhythmia and only 21.2% of cases without arrhythmia during hospitalization. |
T159 | 1994-2191 | Sentence | denotes | Attempts at imputing LVEF and including the imputed dataset in the final logistic regression model hinted at a potential role of LVEF as an additional predictor for arrhythmia incidence (Table S1). |
T160 | 2192-2347 | Sentence | denotes | However, due to the high number of missing values, LVEF was omitted from the final logistic regression model to ensure reliability of statistical analyses. |
T161 | 2348-2533 | Sentence | denotes | With regard to peak levels of cardiac and inflammatory biomarkers assessed during hospitalization, patients with arrhythmia displayed higher levels of hsTnT and NTproBNP (Figure 3A, B). |
T162 | 2534-2756 | Sentence | denotes | Additionally, a more pronounced increase in IL-6 and LDH could be detected in the arrhythmia subgroup, whereas there was no statistically significant difference in peak levels of CRP between groups (Table 2, Figure 3C, D). |